{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:31:19Z","timestamp":1774607479550,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006196","name":"University of Oulu","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04325-y","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T13:27:20Z","timestamp":1753968440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive impairment profile in patients with the m.3243A&gt;\u2009G variant in mitochondrial DNA"],"prefix":"10.1186","volume":"25","author":[{"given":"Satu","family":"Winqvist","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9193-5492","authenticated-orcid":false,"given":"Mikko","family":"K\u00e4rpp\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8041-3205","authenticated-orcid":false,"given":"Jukka S.","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9070-3791","authenticated-orcid":false,"given":"Kari","family":"Majamaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"4325_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.410160409","volume":"16","author":"SG Pavlakis","year":"1984","unstructured":"Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481\u20138. https:\/\/doi.org\/10.1002\/ana.410160409.","journal-title":"Ann Neurol"},{"key":"4325_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/348651a0","volume":"348","author":"Y Goto","year":"1990","unstructured":"Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651\u20133. https:\/\/doi.org\/10.1038\/348651a0.","journal-title":"Nature"},{"key":"4325_CR3","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/brain\/120.10.1713","volume":"120","author":"PF Chinnery","year":"1997","unstructured":"Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain. 1997;120:1713\u201321. https:\/\/doi.org\/10.1093\/brain\/120.10.1713.","journal-title":"Brain"},{"key":"4325_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1196\/annals.1444.011","volume":"1142","author":"DM Sproule","year":"2008","unstructured":"Sproule DM, Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci. 2008;1142:133\u201358. https:\/\/doi.org\/10.1196\/annals.1444.011.","journal-title":"Ann N Y Acad Sci"},{"key":"4325_CR5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(21)00098-3","volume":"20","author":"YS Ng","year":"2021","unstructured":"Ng YS, Bindoff LA, Gorman GS, Klopstock T, Kornblum C, Mancuso M, McFarland R, Sue CM, Suomalainen A, Taylor RW, Thorburn DR, Turnbull DM. Mitochondrial disease in adults: recent advances and future promise. Lancet Neurol. 2021;20:573\u201384. https:\/\/doi.org\/10.1016\/S1474-4422(21)00098-3.","journal-title":"Lancet Neurol"},{"key":"4325_CR6","doi-asserted-by":"publisher","first-page":"100139","DOI":"10.1016\/j.cccb.2022.100139","volume":"3","author":"I Canavero","year":"2022","unstructured":"Canavero I, Rifino N, Montano V, Pantoni L, Gatti L, Pollaci G, Potenza A, Carrozzini T, Finsterer J, Bersano A. Cognitive aspects of MELAS and CARASAL. Cereb Circ Cogn Behav. 2022;3:100139. https:\/\/doi.org\/10.1016\/j.cccb.2022.100139.","journal-title":"Cereb Circ Cogn Behav"},{"key":"4325_CR7","doi-asserted-by":"publisher","first-page":"e8262","DOI":"10.15252\/emmm.201708262","volume":"10","author":"JP Grady","year":"2018","unstructured":"Grady JP, Pickett SJ, Ng YS, Alston CL, Blakely EL, Hardy SA, Feeney CL, Bright AA, Schaefer AM, Gorman GS, McNally RJ, Taylor RW, Turnbull DM, McFarland R. MtDNA heteroplasmy level and copy number indicate disease burden in m.3243A\u2009>\u2009G mitochondrial disease. EMBO Mol Med. 2018;10:e8262. https:\/\/doi.org\/10.15252\/emmm.201708262.","journal-title":"EMBO Mol Med"},{"key":"4325_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2015.06.004","volume":"116","author":"AW El-Hattab","year":"2015","unstructured":"El-Hattab AW, Adesina AM, Jones J, Scaglia F. MELAS syndrome: clinical manifestations, pathogenesis, and treatment options. Mol Genet Metab. 2015;116:4\u201312. https:\/\/doi.org\/10.1016\/j.ymgme.2015.06.004.","journal-title":"Mol Genet Metab"},{"key":"4325_CR9","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archneurol.2008.526","volume":"66","author":"P Kaufmann","year":"2009","unstructured":"Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Battista V, Koenigsberger DY, Pascual JM, Sano M, Hirano M, DiMauro S, Shungu DC, Mao X, De Vivo DC. Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol. 2009;66:85\u201391. https:\/\/doi.org\/10.1001\/archneurol.2008.526.","journal-title":"Arch Neurol"},{"key":"4325_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1212\/WNL.0b013e31823a0c7f","volume":"77","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Sproule DM, Battista V, Koenigsberger DY, Pascual JM, Shanske S, Sano M, Mao X, Hirano M, Shungu DC, Dimauro S, De Vivo DC. Natural history of MELAS associated with mitochondrial DNA m.3243A\u2009>\u2009G genotype. Neurology. 2011;77:1965\u201371. https:\/\/doi.org\/10.1212\/WNL.0b013e31823a0c7f.","journal-title":"Neurology"},{"key":"4325_CR11","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, Kakuma T, Koga Y. Taro Matsuoka for MELAS study group in japan. MELAS: a nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619\u201324. https:\/\/doi.org\/10.1016\/j.bbagen.2011.03.015.","journal-title":"Biochim Biophys Acta"},{"key":"4325_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.mito.2017.12.012","volume":"44","author":"T Kraya","year":"2019","unstructured":"Kraya T, Neumann L, Paelecke-Habermann Y, Deschauer M, Stoevesandt D, Zierz S, Watzke S. Cognitive impairment, clinical severity and MRI changes in MELAS syndrome. Mitochondrion. 2019;44:53\u20137. https:\/\/doi.org\/10.1016\/j.mito.2017.12.012.","journal-title":"Mitochondrion"},{"key":"4325_CR13","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00415-013-7225-3","volume":"261","author":"M Mancuso","year":"2014","unstructured":"Mancuso M, Orsucci D, Angelini C, Bertini E, Carelli V, Comi GP, Donati A, Minetti C, Moggio M, Mongini T, Servidei S, Tonin P, Toscano A, Uziel G, Bruno C, Ienco EC, Filosto M, Lamperti C, Catteruccia M, Moroni I, Musumeci O, Pegoraro E, Ronchi D, Santorelli FM, Sauchelli D, Scarpelli M, Sciacco M, Valentino ML, Vercelli L, Zeviani M, Siciliano G. The m.3243A\u2009>\u2009G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol. 2014;261:504\u201310. https:\/\/doi.org\/10.1007\/s00415-013-7225-3.","journal-title":"J Neurol"},{"key":"4325_CR14","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/acn3.736","volume":"6","author":"HL Moore","year":"2019","unstructured":"Moore HL, Kelly T, Bright A, Field RH, Schaefer AM, Blain AP, Taylor RW, McFarland R, Turnbull DM, Gorman GS. Cognitive deficits in adult m.3243A\u2009>\u2009G- and m.8344A\u2009>\u2009G-related mitochondrial disease: importance of correcting for baseline intellectual ability. Ann Clin Transl Neurol. 2019;6:826\u201336. https:\/\/doi.org\/10.1002\/acn3.736.","journal-title":"Ann Clin Transl Neurol"},{"key":"4325_CR15","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/acn3.51564","volume":"9","author":"EB Leaffer","year":"2022","unstructured":"Leaffer EB, De Vivo DC, Engelstad K, Fryer RH, Gu Y, Shungu DC, Hirano M, DiMauro S, Hinton VJ. Visual memory failure presages conversion to MELAS phenotype. Ann Clin Transl Neurol. 2022;9:841\u201352. https:\/\/doi.org\/10.1002\/acn3.51564.","journal-title":"Ann Clin Transl Neurol"},{"key":"4325_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1086\/301959","volume":"63","author":"K Majamaa","year":"1998","unstructured":"Majamaa K, Moilanen JS, Uimonen S, Remes AM, Salmela PI, K\u00e4rpp\u00e4 M, Majamaa-Voltti KA, Rusanen H, Sorri M, Peuhkurinen KJ, Hassinen IE. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet. 1998;63:447\u201354. https:\/\/doi.org\/10.1086\/301959.","journal-title":"Am J Hum Genet"},{"key":"4325_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC Van Swieten","year":"1988","unstructured":"Van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604\u20137.","journal-title":"Stroke"},{"key":"4325_CR18","volume-title":"Clinical global impressions. Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology","author":"E Guy","year":"1976","unstructured":"Guy E. Clinical global impressions. Early clinical drug evaluation (ECDEU) assessment manual for psychopharmacology. Rockville: National Institute of Mental Health; 1976. pp 218\u2013\u200922."},{"key":"4325_CR19","first-page":"156","volume-title":"WAIS-R manual","author":"D Wechsler","year":"1981","unstructured":"Wechsler D. WAIS-R manual. New York: Psychological Corporation; 1981. p. 156."},{"key":"4325_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/00223980.1945.9917223","volume":"19","author":"D Wechsler","year":"1945","unstructured":"Wechsler D. A standardized memory scale for clinical use. J Psychol. 1945;19:87\u201395.","journal-title":"J Psychol"},{"key":"4325_CR21","first-page":"227","volume-title":"Luria\u00b4s neuropsychological investigation. Text","author":"AL Christensen","year":"1979","unstructured":"Christensen AL. Luria\u00b4s neuropsychological investigation. Text. Copenhagen: Munksgaard; 1979. p. 227."},{"key":"4325_CR22","first-page":"92","volume-title":"The revised visual retention test. Clinical and experimental applications","author":"AL Benton","year":"1974","unstructured":"Benton AL. The revised visual retention test. Clinical and experimental applications. 4th ed. New York: Psychological Corporation; 1974. p. 92.","edition":"4"},{"key":"4325_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"MR Reitan","year":"1958","unstructured":"Reitan MR. Validity of the trail making test as an indication of organic brain damage. Percept Motor Skill. 1958;8:271\u20136.","journal-title":"Percept Motor Skill"},{"key":"4325_CR24","unstructured":"Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press; 1995."},{"key":"4325_CR25","doi-asserted-by":"publisher","DOI":"10.1891\/9780826198259","volume-title":"Statistics for advanced practice nurses and health professionals","author":"M Stommel","year":"2014","unstructured":"Stommel M, Dontje KJ. Statistics for advanced practice nurses and health professionals. 1st ed. New York: Springer Publishing Company; 2014.","edition":"1"},{"key":"4325_CR26","doi-asserted-by":"publisher","first-page":"e000825","DOI":"10.1136\/bmjno-2024-000825","volume":"6","author":"K Majamaa","year":"2024","unstructured":"Majamaa K, K\u00e4rpp\u00e4 M, Moilanen JS. Neurological manifestations in adult patients with the m.3243A\u2009>\u2009G variant in mitochondrial DNA. BMJ Neurol Open. 2024;6:e000825. https:\/\/doi.org\/10.1136\/bmjno-2024-000825.","journal-title":"BMJ Neurol Open"},{"key":"4325_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s11011-021-00772-x","volume":"36","author":"S Tetsuka","year":"2021","unstructured":"Tetsuka S, Ogawa T, Hashimoto R, Kato H. Clinical features, pathogenesis, and management of stroke-like episodes due to MELAS. Metab Brain Dis. 2021;36:2181\u201393. https:\/\/doi.org\/10.1007\/s11011-021-00772-x.","journal-title":"Metab Brain Dis"},{"key":"4325_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/acn3.532","volume":"5","author":"SJ Pickett","year":"2018","unstructured":"Pickett SJ, Grady JP, Ng YS, Gorman GS, Schaefer AM, Wilson IJ, Cordell HJ, Turnbull DM, Taylor RW, McFarland R. Phenotypic heterogeneity in m.3243A\u2009>\u2009G mitochondrial disease: the role of nuclear factors. Ann Clin Transl Neurol. 2018;5:333\u201345. https:\/\/doi.org\/10.1002\/acn3.532.","journal-title":"Ann Clin Transl Neurol"},{"key":"4325_CR29","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","volume":"379","author":"RJ McCrimmon","year":"2012","unstructured":"McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;379:2291\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(12)60360-2.","journal-title":"Lancet"},{"key":"4325_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1620\/tjem.238.311","volume":"238","author":"T Murakami","year":"2016","unstructured":"Murakami T, Shinoto Y, Yonemitsu S, Muro S, Oki S, Koga Y, Goto Y, Kaneda D. Early onset of diabetes mellitus accelerates cognitive decline in Japanese patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and Stroke-Like episodes. Tohoku J Exp Med. 2016;238:311\u20136. https:\/\/doi.org\/10.1620\/tjem.238.311.","journal-title":"Tohoku J Exp Med"},{"key":"4325_CR31","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1093\/brain\/awp259","volume":"132","author":"MM Lindroos","year":"2009","unstructured":"Lindroos MM, Borra R, Parkkola R, Virtanen S, Lepom\u00e4ki V, Bucci M, Virta JR, Rinne J, Nuutila P, Majamaa K. Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A\u2009>\u2009G mutation. Brain. 2009;132:3274\u201384. https:\/\/doi.org\/10.1093\/brain\/awp259.","journal-title":"Brain"},{"key":"4325_CR32","unstructured":"UNESCO Institute for Statistics. (http:\/\/data.uis.unesco.org\/)."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04325-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04325-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:31:24Z","timestamp":1757323884000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04325-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4325"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04325-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Medical Faculty, University of Oulu, and the study conforms with World Medical Association Declaration of Helsinki. Written informed consent has been obtained from each subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"316"}}